Your browser doesn't support javascript.
loading
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer.
Lundberg, Arian; Zhang, Meng; Aggarwal, Rahul; Li, Haolong; Zhang, Li; Foye, Adam; Sjöström, Martin; Chou, Jonathan; Chang, Kevin; Moreno-Rodriguez, Thaidy; Shrestha, Raunak; Baskin, Avi; Zhu, Xiaolin; Weinstein, Alana S; Younger, Noah; Alumkal, Joshi J; Beer, Tomasz M; Chi, Kim N; Evans, Christopher P; Gleave, Martin; Lara, Primo N; Reiter, Rob E; Rettig, Matthew B; Witte, Owen N; Wyatt, Alexander W; Feng, Felix Y; Small, Eric J; Quigley, David A.
Afiliação
  • Lundberg A; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Zhang M; Department of Radiation Oncology, University of California San Francisco, San Francisco, California.
  • Aggarwal R; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Li H; Department of Radiation Oncology, University of California San Francisco, San Francisco, California.
  • Zhang L; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Foye A; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Sjöström M; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Chou J; Department of Radiation Oncology, University of California San Francisco, San Francisco, California.
  • Chang K; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Moreno-Rodriguez T; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.
  • Shrestha R; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Baskin A; Department of Radiation Oncology, University of California San Francisco, San Francisco, California.
  • Zhu X; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Weinstein AS; Department of Radiation Oncology, University of California San Francisco, San Francisco, California.
  • Younger N; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Alumkal JJ; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Beer TM; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Chi KN; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Evans CP; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Gleave M; Department of Urology, University of California San Francisco, San Francisco, California.
  • Lara PN; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Reiter RE; Department of Radiation Oncology, University of California San Francisco, San Francisco, California.
  • Rettig MB; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Witte ON; Department of Radiation Oncology, University of California San Francisco, San Francisco, California.
  • Wyatt AW; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Feng FY; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Small EJ; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Quigley DA; Department of Radiation Oncology, University of California San Francisco, San Francisco, California.
Cancer Res ; 83(16): 2763-2774, 2023 08 15.
Article em En | MEDLINE | ID: mdl-37289025
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Cancer Res Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Cancer Res Ano de publicação: 2023 Tipo de documento: Article